⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5351283 | 0.83 | — | — | |
| SCHEMBL5348718 | 0.81 | — | — | |
| SCHEMBL20901915 | 0.75 | — | — | |
| SCHEMBL6573282 | 0.73 | — | — | |
| SCHEMBL1557563 | 0.71 | — | — | |
| SCHEMBL97960 | 0.71 | — | — | |
| SCHEMBL2589974 | 0.69 | — | — | |
| SCHEMBL28882280 | 0.67 | ALDH1A1 (0.50) | — | |
| SCHEMBL193470 | 0.67 | — | — | |
| SCHEMBL2699217 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 353 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220169671-A1 | NUCLEIC ACID COMPOUND AND OLIGONUCLEOTIDE | OSAKA UNIVERSITY (JP) | 2022-06-02 | — | — | US | claimed |
| US-20220170020-A1 | ANTISENSE OLIGONUCLEIC ACID | OSAKA UNIVERSITY (JP) | 2022-06-02 | — | — | US | claimed |
| US-11261440-B2 | Antisense oligonucleic acid | OSAKA UNIVERSITY (JP) | 2022-03-01 | — | — | US | claimed |
| EP-3587576-A9 | ANTISENSE OLIGONUCLEIC ACID | Osaka University (JP) | 2020-07-29 | — | — | EP | claimed |
| US-20200055890-A1 | NUCLEIC ACID COMPOUND AND OLIGONUCLEOTIDE | OSAKA UNIVERSITY (JP) | 2020-02-20 | — | — | US | claimed |
| US-20200056178-A1 | ANTISENSE OLIGONUCLEIC ACID | OSAKA UNIVERSITY (JP) | 2020-02-20 | — | — | US | claimed |
| EP-2921499-B1 | METHOD FOR LIQUID-PHASE SYNTHESIS OF NUCLEIC ACIDS | TAKEDA PHARMACEUTICALS CO (JP) | 2020-01-22 | — | — | EP | claimed |
| EP-1387843-B1 | METHOD FOR OBTAINING PIOGLITAZONE AS AN ANTIDIABETIC AGENT | ZENTIVA AS (CZ) | 2007-02-28 | — | — | EP | claimed |
| US-RE39072-E1 | 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same | MITSUBISHI PHARMA CORPORATION (JP) | 2006-04-18 | — | — | US | claimed |
| US-7009057-B2 | Method for obtaining pioglitazone as an antidiabetic agent | ZENTIVA A.S. (CZ) | 2006-03-07 | — | — | US | claimed |
| US-4581170-A | N-hydroxyl protecting groups and process and intermediates for the preparation of 3-acylamino-1-hydroxy-2-azetidinones | E. R. SQUIBB & SONS, INC. (US) | 1986-04-08 | — | — | US | claimed |
| EP-0074763-B1 | A COLOR PHOTOGRAPHIC LIGHT-SENSITIVE MATERIAL | KONICA CORPORATION (JP) | 1986-03-05 | — | — | EP | claimed |
| EP-0170280-A1 | Novel intermediates and process for the preparation of 3-acylamino-1-hydroxy-2-azetidinones | E.R. Squibb & Sons, Inc. (US) | 1986-02-05 | — | — | EP | claimed |
| US-4560508-A | BETA-LACTAMASE INHIBITORS, ANINICROBIAL AGENT, CHEMICAL INTERMEDIATE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1985-12-24 | — | — | US | claimed |
| US-4550105-A | BETA-LACTAMASE INHIBITORS, ANTIBIOTICS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1985-10-29 | — | — | US | claimed |
| US-4533495-A | Method of producing 2-azetidinone-1-sulfonic acid compounds | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1985-08-06 | — | — | US | claimed |
| US-4430424-A | AROMATIC PRIMARY AMINE DEVELOPING AGENT | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1984-02-07 | — | — | US | claimed |
| US-4416817-A | BACTERICIDES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1983-11-22 | — | — | US | claimed |
| EP-0074763-A1 | A color photographic light-sensitive material | KONICA CORPORATION (JP) | 1983-03-23 | — | — | EP | claimed |
| EP-0053387-A1 | Method of preparing 1-sulfo-2-oxoazetidine derivatives and intermediates therefor | Takeda Chemical Industries, Ltd. (JP) | 1982-06-09 | — | — | EP | claimed |